Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paraneoplastic syndromes

J Rees1

  • 1St Thomas' Hospital, London, UK.

Current Opinion in Neurology
|December 31, 1998
PubMed
Summary
This summary is machine-generated.

Paraneoplastic neurological syndromes cause severe neurological dysfunction and may lead to diagnosing a curable cancer. These syndromes have diverse presentations, but treatment options and outcomes remain poor.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the impact of behaviour change intervention strategies on the biosecurity knowledge, attitudes, and practices of pig producers in New South Wales, Australia.

Preventive veterinary medicine·2025
Same author

Validation of a novel simulated tendon model for core suture tendon repair.

Annals of the Royal College of Surgeons of England·2024
Same author

Clinical characteristics of people with intellectual disability admitted to hospital with constipation: identifying possible specific high-risk factors.

Journal of intellectual disability research : JIDR·2023
Same author

A 15-year experience: intraoperative parathyroid hormone assay for the management of primary hyperparathyroidism in a UK endocrine surgical unit.

Langenbeck's archives of surgery·2023
Same author

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Central importance of emotional and quality-of-life outcomes in the public's perception of face transplantation.

The British journal of surgery·2021
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
Same journal

Functional movement disorders: diagnosis, pathophysiology, and treatment.

Current opinion in neurology·2026
Same journal

Galectins in the brain: advances in neuroinflammation, neuroprotection and therapeutic opportunities: Erratum.

Current opinion in neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Oncology
  • Immunology

Background:

  • Paraneoplastic neurological syndromes (PNS) are a group of disorders characterized by neurological dysfunction.
  • PNS can be the initial sign of an underlying, potentially curable cancer.
  • The clinical spectrum and antibody associations of PNS are continually expanding.

Purpose of the Study:

  • To review the current understanding of paraneoplastic neurological syndromes.
  • To highlight the expanding range of clinical presentations and antibody associations.
  • To discuss the challenges in management and the generally poor prognosis.

Main Methods:

  • Literature review of paraneoplastic neurological syndromes.
  • Analysis of recent findings on clinical presentations and antibody associations.

Related Experiment Videos

  • Discussion of current therapeutic approaches and outcomes.

    • Main Results:

    • PNS present with a wide variety of neurological symptoms.
    • New antibody targets associated with PNS are regularly identified.
    • Conventional immunosuppressive treatments are often ineffective for PNS.

    Conclusions:

    • Paraneoplastic neurological syndromes represent a significant diagnostic and therapeutic challenge.
    • Early diagnosis of the underlying cancer is crucial for potential cure.
    • Despite advances, the prognosis for patients with PNS remains poor, necessitating further research into effective treatments.